Empowering Arkansas entrepreneurs in healthcare and health tech. Receive comprehensive support and networking opportunities to accelerate your venture. Apply now to join the 2024 cohort and shape the future of healthcare entrepreneurship.
Make a difference by developing technology-driven solutions to enhance healthcare infrastructure, expand access to prenatal and postnatal care, and empower women with the tools they need for better health outcomes.
A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
Recombinant T cell clonotypes are provided that express T cell receptor alpha and T cell receptor beta polypeptides with specificity for human papillomavirus (HPV) type 16 E6 protein and that amplify in response to a therapeutic vaccine and traffic to ovarian lesional tissue in a patient whose HPV lesions regressed in response to the vaccine. Recombinant T cells expressing appropriate TCR alpha and beta complimentarity determining sequences for HPV 16 E6 binding and treating HPV-cased cancers are provided. Bifunctional proteins having TCR alpha and beta segments that bind to HPV 16 E6 residues 91-115 and a single chain Fv anti-CD3 antibody domain are provided. These bifunctional proteins can direct T cells to HPV-infected cells.
A fractionated photoacoustic flow cytometry (PAFC) system and methods for the in vivo detection of target objects in biofluidic systems (e.g., blood, lymph, urine, or cerebrospinal fluid) of a living organism is described. The fractionated system includes a fractionated laser system, a fractionated optical system, a fractionated acoustic system, and combinations thereof. The fractionated laser system includes at least one laser or laser array for pulsing a target object within the circulatory vessel with fractionated focused laser beams. The fractionated optical system separates one or several laser beams into multiple beams in a spatial configuration on the skin above the circulatory vessel of the living organism. The fractionated acoustic system includes multiple focused ultrasound transducers for receiving photoacoustic signals emitted by the target object in response to the fractionated laser beams.
BioVentures was established as a formal outgrowth of the University of Arkansas for Medical Sciences‘ (UAMS) interest in promoting a biomedical technology industry for Arkansas and translating its research into products that benefit human health.
UAMS established BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the development of startup companies that are based on technology developed at UAMS, and contributions to Arkansas’ economic development.
BioVentures links the research minds at UAMS to global markets in order to advance Arkansas’ scientific and economic development.
BioVentures invites the UAMS community to Innovation Week, May 12-15, 2025. Designed to showcase innovation, foster industry connections and highlight the pathway from research to commercialization, Innovation Week offers opportunities for everyone from seasoned inventors and those just starting out. Whether you’re an entrepreneur, inventor, researcher or industry partner, Innovation Week is your chance to engage with the thriving healthcare innovation ecosystem at UAMS and beyond. Innovation Week Highlights Join us to learn, connect and take your ideas to the next level. Learn more & register.
It was a privilege to join fellow innovators at the AUTM Annual Meeting March 2-5 in National Harbor, Maryland, where we celebrated 50 years of propelling technology transfer forward. BioVentures and our colleagues nationwide remain committed to advancing innovation that transforms the future. The BioVentures team learned about the latest industry trends and ideas for accelerating discoveries from the lab to the marketplace. Thank you to everyone who connected with us and contributed to these vital discussions. Keep the conversation going: connect with our team on LinkedIn: Eric Peterson, John Sherrill, Michael Geranen, Stefanie Kennon-McGill
BioVentures will announce the Student Innovator Award on April 17 at Student Research Day. This new opportunity recognizes and supports innovative student research with the potential for translational and commercial success. Visit the BioVentures booth at the event to learn more about intellectual property, patenting, entrepreneurship and commercialization. All Student Research Day participants are eligible – no additional application required. Student Research Day is 3 p.m. to 6:45 p.m. Thursday, April 17, in the I. Dodd Wilson Building, UAMS Little Rock Campus. Thank you to UAMS Research & Innovation, the UAMS Graduate School and the Faculty Academic Senate for organizing this event! Click here to learn more.
401 South Cedar Street Little Rock, Arkansas 72205
(501) 686-6696
bioventures@uams.edu
